Inventor
WILL DAVID WILLIAM
DE36 patents
⚠️ This page may combine multiple inventors who share the name “WILL DAVID WILLIAM”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
SANOFI AVENTIS DEUTSCHLAND
13 patentsUS7910606B2Mar 22, 2011
Pyrazole-derivatives as factor Xa inhibitors
SANOFI AVENTIS DEUTSCHLAND81 citations98
US7067665B2Jun 27, 2006
Oxybenzamide derivatives useful for inhibiting factor Xa or Vlla
SANOFI AVENTIS DEUTSCHLAND75 citations98
US7317027B2Jan 8, 2008
Azaindole-derivatives as factor Xa inhibitors
SANOFI AVENTIS DEUTSCHLAND26 citations92
US7897346B2Mar 1, 2011
Polyamide nucleic acid derivatives and agents, and processes for preparing them
SANOFI AVENTIS DEUTSCHLAND2 citations63
US7727989B2Jun 1, 2010
4-benzimidazol-2-yl-pyridazine-3-one-derivatives, production and use thereof in medicaments
SANOFI AVENTIS DEUTSCHLAND7 citations63
US7309701B2Dec 18, 2007
Pyridazinone derivatives as pharmaceuticals and pharmaceutical compositions containing them
SANOFI AVENTIS DEUTSCHLAND3 citations60
US7709466B2May 4, 2010
Pyridazinone derivatives, methods for their production and their use as pharmaceuticals
SANOFI AVENTIS DEUTSCHLAND1 citations52
US7550582B2Jun 23, 2009
Polyamide nucleic acid derivatives and agents, and processes for preparing them
SANOFI AVENTIS DEUTSCHLAND0 citations52
US7241882B2Jul 10, 2007
Polyamide nucleic acid derivatives, and agents, and processes for preparing them
SANOFI AVENTIS DEUTSCHLAND0 citations52
US7435747B2Oct 14, 2008
Guanidine and amidine derivatives as factor Xa inhibitors
SANOFI AVENTIS DEUTSCHLAND1 citations51
US7968546B2Jun 28, 2011
Pyridazinone kinase inhibitors
SANOFI AVENTIS DEUTSCHLAND1 citations50
US7488818B2Feb 10, 2009
Method for producing 1,4-diphenyl azetidinone derivatives
SANOFI AVENTIS DEUTSCHLAND1 citations49
US7462613B2Dec 9, 2008
Pyridazinone derivatives as pharmaceuticals and pharmaceutical compositions containing them
SANOFI AVENTIS DEUTSCHLAND1 citations49
AVENTIS PHARMA GMBH
9 patentsUS6953857B2Oct 11, 2005
Oxybenzamide derivatives useful for inhibiting factor Xa or viia
AVENTIS PHARMA GMBH69 citations98
US6340679B1Jan 22, 2002
Guanidine derivatives as inhibitors of cell adhesion
AVENTIS PHARMA GMBH48 citations92
US6313119B1Nov 6, 2001
Sulfonamide derivatives as inhibitors of bone resorption and as inhibitors of cell adhesion
AVENTIS PHARMA GMBH32 citations92
US6660728B2Dec 9, 2003
Thienyl substituted acylguanidines as inhibitors of bone resorption and vitronectin receptor antagonists
AVENTIS PHARMA GMBH30 citations91
US6906084B2Jun 14, 2005
Indole derivatives as factor Xa inhibitors
AVENTIS PHARMA GMBH30 citations90
US6905820B2Jun 14, 2005
Polyamide nucleic acid derivatives, and agents and processes for preparing them
AVENTIS PHARMA GMBH7 citations74
US6723706B2Apr 20, 2004
Modified antisense nucleotides complementary to a section of the human Ha-ras gene
AVENTIS PHARMA GMBH12 citations70
US6777544B2Aug 17, 2004
Polyamide nucleic acid derivatives and agents and processes for preparing them
AVENTIS PHARMA GMBH5 citations63
US6566366B1May 20, 2003
Thienyl substituted acylguanidines as inhibitors of bone resorption and vitronectin receptor antagonists
AVENTIS PHARMA GMBH3 citations61
STROBEL HARTMUT
3 patentsUS8304438B2Nov 6, 2012
Heteroarylacrylamides and their use as pharmaceuticals
STROBEL HARTMUT30 citations92
US8299102B2Oct 30, 2012
Heteroarylcyclopropanecarboxamides and their use as pharmaceuticals
STROBEL HARTMUT27 citations92
US8188291B2May 29, 2012
Heteroaryl-substituted carboxamides and their use as pharmaceuticals
STROBEL HARTMUT3 citations62
AVENTIS PHARMA SA
3 patentsZOLLER GERHARD
3 patentsUS8399476B2Mar 19, 2013
Imidazo[1,2-a]pyridines and their use as pharmaceuticals
ZOLLER GERHARD0 citations41
US8168665B2May 1, 2012
Substituted 2-phenyl-benzimidazoles and their use as pharmaceuticals
ZOLLER GERHARD0 citations41
US8080569B2Dec 20, 2011
Imidazo[2,1-b]thiazoles and their use as pharmaceuticals
ZOLLER GERHARD0 citations41
STROBEL HARMUT
2 patentsUS8642620B2Feb 4, 2014
Heteroaryl-substituted amides comprising an unsaturated or cyclic linker group, and their use as pharmaceuticals
STROBEL HARMUT0 citations31
US8518976B2Aug 27, 2013
Heteroaryl-substituted amides comprising a saturated linker group, and their use as pharmaceuticals
STROBEL HARMUT0 citations31